In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dr. Andi White, Head of Business Operations & Strategy for the Healthcare Industry Solutions Accelerator at Microsoft. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andi, covering: How five years at GE helped develop and shape Andi into a leader Why having a broad mindset early on in your career will help you flourish down the...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Charles Ruban, CEO at Verdot. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Charles, covering: Crossing the border from supply chain to R&D, lessons learned from a technician turned business leader Creating the most extensive peanut allergy clinical trial in the world and opting for an IPO instead of a big pharma licensing...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dirk Lange, Head of Life Science Services at MilliporeSigma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dirk, covering: What he has learned from 25 years of bouncing around geographically in terms of cultural differences in understanding clients and colleagues Life on both sides of the fence as a drug sponsor and a CDMO,...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Fredrik Lehmann, Venture Partner at Industrifonden. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Fredrik, covering: How the closing of a business and customer requests led to a phoenix from the flames start-up opportunity His company's journey from inception and growth to eventual sale to Recipharm His transition to becoming a VC...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Belden, President of Tjoapack US. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering:  How the success of a contract packaging operation led to a divestiture from AmerisourceBergen to PCI The fun, games, and complexities of multi-national, M&A integrations Smaller patient populations and personalized...

In this episode of Molecule to Market, tune in for a special announcement about where to find Molecule to Market host, Raman Sehgal, at CPHI Barcelona this month. Listen to the short episode covering: CDMO outlook - the trends and developments Raman expects to see this year and into 2024 A fireside chat with Moderna covering COVID-19 and Oncology Panel moderation on the topic - Why building a collaborative network is essential Are you heading to CPHI this month? Stop by one of Raman’s panels...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bruce Thompson, CEO of Kincell Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Bruce, covering: The daunting and exciting prospect of launching a CDMO spin-out focused on early-phase companies The challenges and opportunities of pivoting a facility from innovator-owned to CDMO-owned Navigating from technical leader to a first...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gordon Nicholson, Director of the Life Sciences NEA at Exyte. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gordon, covering: Transitioning from a regular, technical role into a commercial lead in Asia Lessons from sport and going back to basics when breaking down silos at Novo Nordisk Engineering Tips for building a presence and...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Matthew Stober, Chief Executive Officer at Abzena. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Matt, covering: How the failure of a big pharma R&D portfolio led to the creation of a CDMO business and a pipeline-ready facility Leadership lessons for transitioning from a functional leader to an enterprise-level one, and being...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with J.D. Mowery, President and Chief Executive Officer at KBI Biopharma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with J.D., covering: The experience of bringing a product to market... and then many years later seeing that product used on his wife to help bring his sons into the world How bringing a commercial facility online for...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with TJ Higley, CEO at Microsize. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with TJ, covering: The fast, easy, scalable, precise, and non-patent-protected benefits of micronization How a synergistic capability alliance led to the eventual sale of his business to Lonza Capsugel The risks and realities of being an entrepreneur acquiring...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Howard Berman, CEO and Chairman of the Board at Coya Therapeutics Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Howard, covering: How a neurology appointment with his father led to the creation of a biotech company focused on neurodegenerative, autoimmune, and metabolic diseases Having the DNA of an entrepreneur but taking the...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Pamela Bush, Chief Business Officer at Predictive Oncology. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Pam, covering: The key aspects to successful deal-making learned over a decade with Eli Lily How a passion for curing cancer led Pamela to an opportunity to impact thousands of promising candidates directly How active machine...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tushar Misra, Chief Manufacturing Officer at Mersana Therapeutics. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tushar covering: How his opportunistic nature led him to several roles, companies and locations across the processing and biopharmaceutical sector Being given the task of building a worldwide manufacturing and supply...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mike Martin, Chief Executive Officer at CAI. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mike, covering: How a passion for engineering led to a lifetime in life sciences - including 32 years with Eli Lilly Why working in China, Puerto Rico, and Ireland and the exposure to new cultures changed this ‘mid-west farm boy’s view of...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kathy Fernando, Senior Vice President and Global Head of Pfizer Ignite and Pfizer CentreOne. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kathy, covering: How the forgotten step-child that is mRNA rose to the top of the technology vaccine tree Some of the key ingredients of the secret sauce that has dramatically improved the...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tim Scott, President and CEO, AustinPx. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tim, covering:  The founding story of Pharmatek, and how client centricity and ‘training the hell out of the team’ contributed to the growth How the niche of being a spray drying expert led to a sale of Pharmatek to Catalent... and why he didn’t...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Graham Wylie, Executive Chairman at the Medical Research Network (MRN). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Graham, covering: Transitioning from Pfizer’s in-house R&D team to a senior commercial BD role at Parexel The brutal experience of leading an MBO deal and why you should go into any deal with ‘your eyes...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:   James Edgar, Chief People Officer at Sygnature Discovery Andrew Mears, CEO and Co-founder at Lead Candidate Laura Child, Head of Research and Strategy at ramarketing   Your host, Raman Sehgal, discusses pharmaceutical and biotechnology talent challenges and solutions with his guests, covering: Where the industry-wide talent challenge originates, and practical solutions...

  In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alok Tayi, Founder and CEO at Vibe Bio.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Alok, covering:   The personal story that motivated and inspired Alok to create a rare disease platform focused entirely on creating an ecosystem focused on high potential medicines. Lessons from ‘the grind’ of raising over $100m in capital,...

In this special episode of Molecule to Market, instead of going inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, you'll hear a special announcement about the show moving to Toronto!The announcement reveals why our show sponsor, ramarketing is opening a new office in Canada and what this means for your favorite podcast and host. Listen to the short episode to hear:   About the drivers behind ramarketing's decision to establish a second office in...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Barbara Morgan, Global Vice-President of Pharma and Biotechnology at Kerry.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Barbara, covering: Believing in herself and being brave enough to leave a company that felt like family in a job that she loved Why Pharma has proved itself to be indispensable, while the biopharma slowdown...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Marcel Velterop, CEO and Member of the Board at Primopus. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Marcel, covering: Tips for technical people looking to transition and navigate into a commercial career path Why the CDMO business is not for the faint-hearted given the brutal focus on execution and results Insights from a...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jesse McCool, Co-Founder and CEO at Wheeler Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jesse, covering: His journey from the Lonza bench to the boardroom as CEO of Cytovance CEO before becoming a founder Building a CDMO from a blank canvas via a pit stop of C19 testing What makes Oklahoma City an attractive place to do...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Lung-I Cheng, Vice President of Cell & Gene Therapy at AmerisourceBergen. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Lung-I, covering: His take on the different models of healthcare he has seen globally, and the value they do and don’t deliver to patients The access, and infrastructural challenges of CGT products and ways...